IQVIA Holdings (IQV) Gets a Buy from RBC Capital
In a report released yesterday, Ryan Halsted from RBC Capital maintained a Buy rating on IQVIA Holdings, with a price target of $221.00.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Halsted is an analyst with an average return of -9.2% and a 32.00% success rate. Halsted covers the Healthcare sector, focusing on stocks such as Doximity, Sotera Health, and Medpace Holdings.
In addition to RBC Capital, IQVIA Holdings also received a Buy from Evercore ISI’s Elizabeth Anderson CFA in a report issued on April 8. However, on April 7, Citi assigned a Hold rating to IQVIA Holdings (NYSE: IQV).
Based on IQVIA Holdings’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $4.36 billion and a net profit of $514 million. In comparison, last year the company earned a revenue of $3.96 billion and had a net profit of $437 million
Read More on IQV:
Disclaimer & DisclosureReport an Issue
- Iqvia price target lowered to $185 from $225 at Evercore ISI
- IQVIA: New Segment Structure Enhances Transparency Without Changing Bullish Earnings Outlook
- Netflix resumed, Starbucks downgraded: Wall Street’s top analyst calls
- Iqvia upgraded to Buy from Hold at TD Cowen
- IQVIA: AI-Driven Efficiency Gains, Reinforced Trial Demand, and Attractive Valuation Support Buy Rating
